Target Name: WDR11-DT
NCBI ID: G283089
Other Name(s): RP11-323P17.1 | WDR11-AS1 | WDR11 divergent transcript

WDR11-DT: A Potential Drug Target for Cancer

WDR11-DT, also known as RP11-323P17.1, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. The gene is located on chromosome 11 and has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

Recent studies have suggested that WDR11-DT may be a good candidate for drug development due to its involvement in the regulation of key cellular processes that have been implicated in the development and progression of many diseases, including cancer. The gene has also been shown to be expressed in a variety of tissues and has been shown to be involved in the development of cancer in various models, including human models.

One of the key reasons for the potential drug-development potential of WDR11-DT is its involvement in the regulation of cell growth and differentiation. Studies have shown that WDR11-DT is involved in the regulation of cell growth, cell division, and cell survival. This is important because changes in these processes can contribute to the development and progression of cancer.

Another potential drug-development target for WDR11-DT is its involvement in the regulation of cell survival. Studies have shown that WDR11-DT is involved in the regulation of cell survival and that this is important for the development and progression of cancer. This is because changes in cell survival can contribute to the development and progression of cancer.

In addition to its involvement in cell growth and cell survival, WDR11-DT has also been shown to be involved in the regulation of cell differentiation. Studies have shown that WDR11-DT is involved in the regulation of cell differentiation and that this is important for the development and progression of cancer. This is because changes in cell differentiation can contribute to the development and progression of cancer.

Overall, the potential drug-development potential of WDR11-DT is based on its involvement in the regulation of key cellular processes that have been implicated in the development and progression of many diseases, including cancer. Further research is needed to fully understand the potential drug-development potential of WDR11-DT and to determine the most effective way to use it as a treatment.

Protein Name: WDR11 Divergent Transcript

More Common Targets

WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A